Nifty

:

23349.90

Sensex

:

77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Login

Nifty
Sensex

:
:

23349.90
77155.79

-168.60 (-0.72%)
-422.59 (-0.54%)

Lasa Supergenerics Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 540702 | NSE: LASA

Watchlist

NSE BSE

24.58

05-Jul-2024

Open
High
Low
Previous Close

24.20
25.30
23.56
23.96

Volume
Traded Value (lacs)
52 Week High
52 Week Low

196055
48.23
41.20
19.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

122.00
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

142.58
N/A
1.30

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-9.01
-8.71

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-40.58
-32.65

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
59.75

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
1.40
1.21

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
594.83
986.41

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 30.84 30.56 0.92% 22.82 35.32 -35.39% 26.66 31.71 -15.93% 24.30 33.66 -27.81%
Expenses 29.04 26.51 9.54% 26.80 30.98 -13.49% 25.61 34.17 -25.05% 23.26 34.00 -31.59%
EBITDA 1.80 4.05 -55.56% -3.98 4.34 - 1.05 -2.46 - 1.04 -0.34 -
EBIDTM 5.83% 13.25% -17.44% 12.28% 3.95% -7.77% 4.30% -1.01%
Other Income 0.01 0.00 0 0.01 0.93 -98.92% 0.00 0.86 -100.00% 0.08 0.00 0
Interest 0.87 0.37 135.14% 0.56 0.42 33.33% 0.44 0.43 2.33% 0.56 0.84 -33.33%
Depreciation 2.79 2.65 5.28% 2.66 4.17 -36.21% 2.68 3.09 -13.27% 2.68 3.09 -13.27%
PBT -1.86 1.03 - -15.97 -19.21 - -2.06 -5.12 - -2.11 -6.74 -
Tax 0.87 5.98 -85.45% -0.67 -4.21 - -0.61 -0.20 - -2.09 -0.13 -
PAT -2.73 -4.95 - -15.30 -15.00 - -1.46 -4.92 - -0.02 -6.61 -
PATM -8.86% -16.20% -67.05% -42.47% -5.47% -15.51% -0.09% -19.63%
EPS -0.55 -0.99 - -3.05 -2.99 - -0.29 -0.98 - 0.00 -1.32 -

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 104.62 104.33 129.57 137.13 202.38 167.26 169.57 243.53 198.75 0.00 Net Sales Growth -20.29% -19.48% -5.51% -32.24% 21.00% -1.36% -30.37% 22.53% 0 Cost Of Goods Sold 76.99 75.22 106.11 91.29 112.35 94.66 127.95 171.51 130.89 0.00 Gross Profit 27.63 29.12 23.45 45.83 90.03 72.60 41.63 72.02 67.86 0.00 GP Margin 26.41% 27.91% 18.10% 33.42% 44.49% 43.41% 24.55% 29.57% 34.14% 0 Total Expenditure 104.71 102.11 136.17 121.11 155.17 137.29 158.52 202.26 153.23 0.00 Power & Fuel Cost - 7.45 7.72 7.06 8.06 7.92 6.71 6.64 6.03 0.00 % Of Sales - 7.14% 5.96% 5.15% 3.98% 4.74% 3.96% 2.73% 3.03% 0 Employee Cost - 5.37 6.35 7.15 14.01 13.42 11.74 10.27 9.55 0.00 % Of Sales - 5.15% 4.90% 5.21% 6.92% 8.02% 6.92% 4.22% 4.81% 0 Manufacturing Exp. - 7.89 6.22 5.33 9.45 7.84 5.97 7.28 3.53 0.00 % Of Sales - 7.56% 4.80% 3.89% 4.67% 4.69% 3.52% 2.99% 1.78% 0 General & Admin Exp. - 4.85 5.26 6.52 6.07 3.53 3.47 3.63 2.12 0.00 % Of Sales - 4.65% 4.06% 4.75% 3.00% 2.11% 2.05% 1.49% 1.07% 0 Selling & Distn. Exp. - 0.92 1.75 1.95 3.74 3.12 1.01 0.98 0.25 0.00 % Of Sales - 0.88% 1.35% 1.42% 1.85% 1.87% 0.60% 0.40% 0.13% 0 Miscellaneous Exp. - 0.42 2.76 1.80 1.49 6.81 1.67 1.95 0.86 0.00 % Of Sales - 0.40% 2.13% 1.31% 0.74% 4.07% 0.98% 0.80% 0.43% 0 EBITDA -0.09 2.22 -6.60 16.02 47.21 29.97 11.05 41.27 45.52 0.00 EBITDA Margin -0.09% 2.13% -5.09% 11.68% 23.33% 17.92% 6.52% 16.95% 22.90% 0 Other Income 0.10 0.10 1.84 0.28 0.18 0.23 0.54 3.49 2.17 0.00 Interest 2.43 1.99 4.19 0.06 2.06 8.12 8.38 11.35 11.68 0.00 Depreciation 10.81 10.67 13.42 14.51 15.82 17.34 19.31 18.17 7.69 0.00 PBT -22.00 -10.34 -22.37 1.72 29.49 4.74 -16.10 15.23 28.33 0.00 Tax -2.50 2.62 -3.64 -0.81 6.71 1.11 -4.07 2.89 -0.22 0.00 Tax Rate 11.36% -13.71% 8.61% 13.19% 22.75% 23.42% 25.28% 18.98% -10.28% 0.00% PAT -19.51 -21.73 -38.62 -5.33 22.78 3.63 -12.03 12.34 2.36 0.00 PAT before Minority Interest -19.51 -21.73 -38.62 -5.33 22.78 3.63 -12.03 12.34 2.36 0.00 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -18.65% -20.83% -29.81% -3.89% 11.26% 2.17% -7.09% 5.07% 1.19% 0 PAT Growth 0.00% - - - 527.55% - - 422.88% 0 EPS -3.89 -4.34 -7.71 -1.06 4.55 0.72 -2.40 2.46 0.47 0.00

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 96.68 118.29 157.88 158.92 141.47 105.30 117.34 75.49 0.05 Share Capital 50.10 50.10 50.10 40.67 40.67 22.86 22.86 0.05 0.05 Total Reserves 46.58 68.18 107.78 118.24 100.79 82.43 94.48 54.87 0.00 Non-Current Liabilities 5.32 2.84 6.54 8.41 11.43 43.06 62.17 82.76 0.35 Secured Loans 0.00 0.00 0.00 0.00 13.70 47.67 15.99 31.64 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.44 -1.94 44.28 49.04 0.35 Long Term Provisions 0.47 0.61 0.63 0.59 0.46 0.36 0.24 0.14 0.00 Current Liabilities 48.87 42.73 44.75 40.54 75.92 107.12 107.27 69.99 0.00 Trade Payables 14.05 9.43 16.91 12.72 33.73 59.67 47.94 25.38 0.00 Other Current Liabilities 23.56 23.16 21.82 21.48 16.88 21.95 25.27 17.25 0.00 Short Term Borrowings 0.00 0.00 0.00 0.00 20.34 23.00 29.83 23.19 0.00 Short Term Provisions 11.26 10.14 6.02 6.34 4.97 2.49 4.23 4.18 0.00 Total Liabilities 150.87 163.86 209.17 207.87 228.82 255.48 286.78 228.24 0.40 Net Block 109.76 118.96 137.28 142.95 152.19 161.69 169.64 118.83 0.00 Gross Block 230.18 228.70 233.77 226.12 219.54 211.87 200.58 131.61 0.00 Accumulated Depreciation 120.42 109.74 96.49 83.17 67.35 50.17 30.94 12.78 0.00 Non Current Assets 112.98 124.63 142.87 143.54 152.94 169.64 177.60 148.84 0.00 Capital Work in Progress 2.51 4.64 4.58 0.00 0.00 7.21 7.24 29.51 0.00 Non Current Investment 0.00 0.39 0.38 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 0.71 0.59 0.63 0.59 0.75 0.74 0.72 0.50 0.00 Other Non Current Assets 0.00 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 37.89 39.22 66.30 64.32 75.87 85.84 109.18 79.41 0.05 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 19.04 13.90 11.50 17.26 26.30 31.60 42.23 33.46 0.00 Sundry Debtors 3.59 2.48 18.56 14.77 20.65 28.88 42.15 34.97 0.00 Cash & Bank 1.50 2.39 17.22 4.40 6.06 2.69 2.63 1.16 0.05 Other Current Assets 13.77 0.01 0.09 0.01 22.86 22.67 22.16 9.82 0.00 Short Term Loans & Adv. 13.71 20.44 18.94 27.89 22.76 22.60 22.06 9.76 0.00 Net Current Assets -10.98 -3.51 21.55 23.79 -0.05 -21.28 1.91 9.41 0.05 Total Assets 150.87 163.85 209.17 207.86 228.81 255.48 286.78 228.25 0.40

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 2.14 -17.30 9.21 41.31 13.62 40.66 40.35 -3.00 -0.35 PBT -19.11 -22.37 1.72 29.49 4.74 -16.10 15.23 2.14 0.00 Adjustment 8.42 -4.07 6.50 17.75 25.27 27.20 26.07 17.33 0.00 Changes in Working Capital 12.83 9.18 3.59 -5.93 -16.01 33.11 1.34 -22.14 -0.35 Cash after chg. in Working capital 2.14 -17.26 11.81 41.31 13.99 44.20 42.65 -2.67 -0.35 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 -0.04 -2.59 0.00 -0.37 -3.54 -2.30 -0.33 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -0.40 11.19 -2.91 -3.60 -1.63 -7.34 -44.41 0.38 0.00 Net Fixed Assets 0.65 5.01 -12.23 -6.58 -0.46 -11.26 -46.70 -161.12 Net Investments 0.39 -0.01 -0.38 0.00 0.00 0.00 0.00 0.00 Others -1.44 6.19 9.70 2.98 -1.17 3.92 2.29 161.50 Cash from Financing Activity -1.93 -4.16 -0.04 -36.44 -9.85 -33.40 4.41 0.05 0.40 Net Cash Inflow / Outflow -0.19 -10.27 6.26 1.27 2.15 -0.08 0.35 -2.57 0.05 Opening Cash & Equivalents 0.80 11.07 4.81 2.57 0.42 0.50 0.14 2.71 0.00 Closing Cash & Equivalent 0.61 0.80 11.07 3.84 2.57 0.42 0.50 0.14 0.05

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 19.30 23.61 31.51 39.07 34.78 46.05 51.32 10983.28 -60.18 ROA -13.81% -20.71% -2.56% 10.43% 1.50% -4.44% 4.79% 2.07% 0.00% ROE -20.22% -27.97% -3.37% 15.17% 2.94% -10.81% 14.33% 8.65% 0.00% ROCE -13.23% -23.94% -3.41% 17.14% 6.77% -3.73% 12.80% 14.45% 0.00% Fixed Asset Turnover 0.45 0.56 0.60 0.91 0.78 0.82 1.48 1.66 0.00 Receivable days 10.61 29.63 44.35 31.94 54.04 76.45 57.25 58.49 0.00 Inventory Days 57.63 35.78 38.27 39.28 63.18 79.46 56.19 55.96 0.00 Payable days 56.97 45.30 59.24 75.46 117.22 116.80 60.64 30.02 0.00 Cash Conversion Cycle 11.27 20.11 23.39 -4.24 0.00 39.11 52.80 84.43 0.00 Total Debt/Equity 0.23 0.18 0.13 0.12 0.34 0.80 0.91 2.11 -1.16 Interest Cover -8.60 -9.09 -93.74 15.28 1.58 -0.92 2.34 1.18 0.00

Top Investors:

bnp enterprises

Annual Reports:

News Update:

Lasa Supergenerics gets patent from Controller of Patents
13th Sep 2024, 16:52 PM

The company has been granted patent for an invention ‘Processes For Preparation And Purification Of 5-Chloro-2-Nitroaniline’
Read More
Lasa Supergenerics - Quarterly Results
14th Aug 2024, 16:56 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback